| Stage | MRCY | % of rev | HUBB | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $290M | 100.00% | $1.9B | 100.00% | HUBB ×6.46 |
| Gross profit | $89M | 30.57% | $688M | 36.75% | HUBB +6.2pp |
| Operating income | $14M | 4.99% | $409M | 21.83% | HUBB +16.8pp |
| Pre-tax income | $8M | 2.69% | $345M | 18.44% | HUBB +15.8pp |
| Net income | $798,000 | 0.28% | $265M | 14.13% | HUBB +13.9pp |
| Stage | MRCY | HUBB | Gap · A − B |
|---|---|---|---|
| Revenue | $290M100.00% | $1.9B100.00% | HUBB ×6.46 |
| Gross profit | 30.57%$89M | 36.75%$688M | HUBB +6.2pp |
| Operating income | 4.99%$14M | 21.83%$409M | HUBB +16.8pp |
| Pre-tax income | 2.69%$8M | 18.44%$345M | HUBB +15.8pp |
| Net income |
| 0.28%$798,000 |
| 14.13%$265M |
| HUBB +13.9pp |
No shared counterparties.